Teaching Students How to Handle the Stress of College
November 3, 2016
FOR IMMEDIATE RELEASE
West Texas A&M’s Educational Pros take center stage on Lifetime®.
(DEERFIELD BEACH, Fla. – PR LOG – November 2, 2016) The Balancing Act® welcomes the experts on everything college, Friday, November 4 and Wednesday, November 9, 2016 at 7:30 a.m. (ET/PT) on Lifetime®.
Don’t miss this special guest on The Balancing Act:
Managing Stress – with West Texas A&M
The average college student really has their work cut out for them. From living with a new roommate, to dealing with deadlines and tuition cost, it can be easy to get overwhelmed. And despite the new generation’s affinity for seeking help online, clicking a mouse is no match for a friendly, personalized tip or two. That’s where West Texas A&M University comes in. Their Educational Pros are the go-to experts for higher education needs, and can make the difference between academic success and frustration. Plus, the University offers some of the most highly accredited programs and job placement rates in the country, as well as some of the most competitive tuition rates. Learn everything you need to know, and find more tips from the pros at www.wtamu.edu.
About The Balancing Act®
Entering its eighth season, The Balancing Act continues to empower women in all aspects of their lives. The mission is simple – to provide positive solutions that help today’s modern women balance it all. Entertaining, educational and trusted by women, viewers can tune in to America’s premiere morning show weekday mornings at 7:30 a.m. (ET/PT) on Lifetime Television. For additional information or to view a segment visit: www.thebalancingact.com.
Join the Conversation!
Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.